ATTACHMENT B_SOO ATTACHMENT_36C10X21Q0231.docx
DOCX document 18 KB Posted
- Solicitation number
- 36C10X21Q0231
About this file
This solicitation is for a clinical pathway template acquisition to develop oncology clinical pathways for the Department of Veterans Affairs. Key requirements include developing pathways for various cancer types using templates that can be customized and maintained within the VA's electronic medical record system. Templates are preferred that allow self-service authoring and automatic clinical decision support updates. Related tools for inclusion of clinical trial criteria are also desired.
The solicitation will be conducted as a tiered evaluation for Service-Disabled Veteran-Owned Small Businesses, then Veteran-Owned Small Businesses, followed by other Small Businesses if necessary, and finally Large Businesses. Quotes are due by September 1, 2021 and the contract period of performance is from September 27, 2021 to September 26, 2024, with optional extensions. Pricing shall be fixed-price according to the provided schedule. The primary evaluation factors are technical approach and price.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| 36C10X21Q0231 0001_1.docx | DOCX document | |
| ATTACHMENT D_Questions_36C10X21Q0231_Vendor Questions_Final.xlsx | XLSX spreadsheet | |
| 36C10X21Q0231.docx | DOCX document | |
| ATTACHMENT C_PriceCostSchedule_36C10X21Q0231.xlsx | XLSX spreadsheet | |
| ATTACHMENT A_SOO _36C10X21Q0231_Final.docx | DOCX document | |
| ATTACHMENT D_Questions_36C10X21Q0231.xlsx | XLSX spreadsheet |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
SOO Attachment B
Clinical Pathway Cancer Types *Those bolded are highest priority Adult patients only (no need for malignancies of childhood)
· Hematological malignancies
· Acute Lymphoblastic Leukemia
· Acute Myeloid Leukemia
· B-Cell Lymphomas
· Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
· Chronic Myeloid Leukemia
· Hairy Cell Leukemia
· Hodgkin Lymphoma
· Multiple Myeloma
· Myelodysplastic Syndromes
· Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Fusion Genes
· Myeloproliferative Neoplasms
· Primary Cutaneous Lymphomas
· Systemic Light Chain Amyloidosis
· Systemic Mastocytosis
· T-Cell Lymphomas
· Waldenströms Macroglobulinemia/Lymphoplasmacytic Lymphoma
· Head and Neck Cancer
· Thoracic Malignancies
· Malignant Pleural Mesothelioma
· Non-Small Cell Lung Cancer
· Small Cell Lung Cancer
· Thymomas and Thymic Carcinomas
· Gastrointestinal malignancies
· Anal Carcinoma
· Colon Cancer
· Esophageal and Esophagogastric Junction Cancers
· Gastric Cancer
· Hepatobiliary Cancers
· Pancreatic Adenocarcinoma
· Rectal Cancer
· Small Bowel Adenocarcinoma
· Genitourinary Malignancies
· Bladder Cancer
· Kidney Cancer
· Penile Cancer
· Prostate Cancer
· Skin Malignancies
· Basal Cell Skin Cancer
· Cutaneous Melanoma
· Merkel Cell Carcinoma
· Squamous Cell Skin Cancer
· Breast Cancer
· Sarcomas
· AIDS-Related Kaposi Sarcoma
· Bone Cancer
· Dermatofibrosarcoma Protuberans
· Soft Tissue Sarcoma
· Central Nervous System Cancers
· Gynecological Malignancies
· Cervical Cancer
· Ovarian Cancer
· Uterine Neoplasms
· Vulvar Cancer
· Germ Cell Malignancies
· Gestational Trophoblastic Neoplasia
· Testicular Cancer
· Endocrine Malignancies
· Neuroendocrine and Adrenal Tumors
· Thyroid Carcinoma
· Uveal Melanoma
· Malignancy of Unknown Primary/Occult Primary
File details come from the government source that posted it. Updated .